Executive Search Success Story: Building a Regulatory Team for a Pharma-Device Hybrid Company

How JRG Partners executed a confidential, multi-role regulatory affairs retained search strategy that equipped a global pharmaceutical and medical device hybrid company with the critical leadership required to align pharmaceutical and device strategies, manage simultaneous international submissions, and support accelerated clinical timelines.

The Challenge

A global pharmaceutical and medical device hybrid company developing next-generation combination products was managing simultaneous FDA and international submissions. To support its accelerated clinical timelines and streamline its time-to-market across multiple geographies, the enterprise needed to overhaul its regulatory oversight structure and harmonize its technical pathways. Leadership identified several critical operational and structural pressures:

• Managing complex, simultaneous FDA and international regulatory submissions
• Aligning distinct pharmaceutical and medical device regulatory strategies under a cohesive framework
• Supporting accelerated clinical development timelines for complex portfolios
• Building scalable global compliance frameworks tailored for next-generation combination products
• Expanding regulatory capabilities across multiple distinct therapeutic areas simultaneously
• Addressing critical succession planning gaps within senior regulatory leadership roles

The enterprise determined that stabilizing its multi-site clinical operations required a synchronized corporate management structure spanning a Chief Regulatory Officer, VP Regulatory Affairs for Combination Products, Global Head of Regulatory Strategy, Director of Regulatory Operations, Head of Quality & Regulatory Compliance, Regulatory Intelligence Lead, and senior submission strategy leaders. Successfully executing this multi-role mandate required an executive search partner combining technical vertical literacy in pharma-device interfaces with a direct line to a global pool of passive compliance talent. For organizations assessing how distinct medical device platforms scale post-market compliance architectures outside of therapeutic drug-device integration lines, a parallel analysis can be reviewed in Regulatory_Affairs_Combination_Products_A_Whitelabeled.docx.

Why They Chose JRG Partners

Deep Pharma-Device Regulatory Specialization

Unlike generalist recruiting agencies that lack functional immersion in intersecting biological and mechanical frameworks, JRG Partners maintains dedicated search practices focused explicitly on combination product regulatory affairs, global submission strategy, and compliance leadership. Our consultants carry a detailed operational understanding of multi-jurisdictional lifecycles and the specialized governance standards required to support continuous product innovation.

Real Access to Passive Talent

The most capable global regulatory strategists and compliance executives are typically fully integrated into high-performing corporate systems, meaning they rarely monitor traditional job listings. JRG Partners bypassed conventional recruitment channels entirely, leveraging long-standing sector relationships, proprietary market intelligence, and executive networks to directly engage high-performing passive leaders invisible through conventional channels.

Confidential Search Execution

Because this leadership architecture was built during a critical filing phase where simultaneous global submissions were at stake, absolute discretion was mandatory to protect market continuity and organizational positioning. JRG Partners deployed a highly secure, confidential vetting and outreach framework that successfully insulated the client’s strategic positioning, protected commercial IP, and maintained total candidate trust throughout the recruitment lifecycle.

Global Sourcing Reach

Sourcing specialized regulatory executives capable of navigating contrasting international frameworks required an outreach strategy unconstrained by geographic boundaries. JRG Partners executed a coordinated talent acquisition strategy targeting top-performing leaders from pharmaceutical, medical device, and combination product organizations spanning major life sciences corridors globally.

Our Corporate Search Strategy

Phase 1 — Leadership Assessment & Growth Alignment

Our consultants partnered directly with the board and executive team to map existing structural gaps, identify hidden succession risks, clarify filing milestones, and define the exact leadership competencies required for long-term clinical integration. Rather than matching candidates against legacy job descriptions, we built forward-looking executive profiles dynamically tied to the enterprise’s long-term global commercialization strategy.

Phase 2 — Multi-Sector Market Mapping

JRG Partners executed an exhaustive market-mapping initiative targeting process-driven life sciences, biotech, and regulatory environments globally. Our comprehensive market map targeted key talent pools across pharmaceutical companies, medical device organizations, biotech firms, combination product innovators, global regulatory consulting firms, and contract research organizations (CROs).

Phase 3 — Targeted Executive Engagement

Using a research-driven, highly discreet outreach framework, our consultants directly contacted and evaluated high-achieving corporate leaders with verified records of success in aligning pharmaceutical and medical device strategies. Only candidates demonstrating clear, measurable operational impact and rigorous submission fluency advanced to the final evaluation round.

Phase 4 — Rigorous Assessment & Final Selection

Each finalist candidate underwent an extensive evaluation process looking far beyond basic professional credentials. Our consultants conversion-tested strategic and functional capabilities, international submission agility, team-building and leadership philosophies, regulatory intelligence methods, and long-term retention potential.

Key Outcomes

• 325+ senior corporate regulatory affairs, compliance, and drug-device integration executive profiles systematically mapped across major North American, European, and Asian life sciences hubs.
• Successfully placed and integrated a complete global regulatory leadership framework—spanning the Chief Regulatory Officer, vice presidents, and global strategists—through a targeted retained search.
• Unified separate pharma and device filing assets under a single, cohesive clinical strategy by installing process-driven regulatory operations and intelligence leaders.
• Accelerated international market validation and standardized product lifecycles by placing forward-thinking combination products heads and submission strategy leads.
• Mitigated long-term operational risks and optimized approval timelines by placing specialized, data-driven regulatory affairs leaders.
• Protected crucial filing data, sensitive clinical protocols, and corporate expansion metrics during high-stakes transition phases through strict search confidentiality.
• Provided the Board of Directors and CEO with a high-performance management framework explicitly equipped to eliminate compliance gaps and drive profitable technical innovation at scale.